Cipla
Search results
Our global manufacturing footprint helps us deliver quality pharmaceuticals around the world.
Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals Inc. (LPI), the company's US subsidiary is a $891 million enterprise. It has a presence in the branded and generics markets of the US. In the branded business, Lupin operates in the CVS and Pediatric segments.
2 days ago · Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 84,118.77 Crore) operating in Pharmaceuticals sector. Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Services, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2023.
Jul 13, 2024 · Mumbai: Global pharma major Lupin Limited today announced that the Company has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Topiramate Extended-Release Capsules, 25 mg, 50 mg, 100 mg, and 200 mg, to market a generic equivalent of Trokendi XR Extended-Release ...
There is only one reason why we exist — to treat diseases, to heal and enrich human life. | Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and...
2 days ago · ETHealthWorld. Updated On Jul 18, 2024 at 06:27 PM IST. Mumbai: Pharma company, Lupin Limited (Lupin) today announced that it has signed a license and supply agreement with Huons Co. Ltd for the ...
Jul 14, 2024 · Updated On Jul 14, 2024 at 12:13 PM IST. New Delhi: Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic medication to treat seizures. The ...
